Updates on COVID-19 in Patients with Blood Cancer

John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY

Recorded on December 16, 2021

As 2021 comes to a close, the COVID-19 pandemic continues to evolve. In this episode, Dr. John Leonard, from Weill Cornell Medicine, New York Presbyterian Hospital, discusses the latest updates on how COVID-19 affects the blood cancer patient population. What is the value of the vaccine in blood cancer patients who are on treatment that diminishes immune response? What are the risks and benefits of an mRNA vaccine? What does treatment look like in both symptomatic and asymptomatic patients? How are we seeing the Omicron variant affecting this? Tune in to this important discussion today!

John P. Leonard, MD
John P. Leonard, MD
Senior Associate Dean for Innovation and Initiatives
Executive Vice Chair, Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine, New York Presbyterian
New York, NY

Leave a Reply

Your email address will not be published. Required fields are marked *